Gram-negative bacillary meningitis after cranial surgery or trauma in adults

被引:49
作者
Briggs, S [1 ]
Ellis-Pegler, R [1 ]
Raymond, N [1 ]
Thomas, M [1 ]
Wilkinson, L [1 ]
机构
[1] Auckland Hosp, Dept Infect Dis, Infect Dis Unit, Auckland, New Zealand
关键词
D O I
10.1080/00365540410027193
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In order to assess the clinical features, aetiology, treatment and outcome of post-neurosurgical and post-traumatic Gram-negative bacillary meningitis (GNBM) we performed a retrospective review of all adult patients admitted to the Department of Neurosurgery who had Gram-negative bacilli cultured from cerebrospinal fluid (CSF) following a neurosurgical procedure or traumatic head/spinal injury. During the 12 y of the review 33 patients had CSF isolates of Gram-negative bacilli that were thought to be significant. The median patient age was 47 y (range 22-77 y) and 21 (64%) were male. Klebsiella pneumoniae, Enterobacter cloacae and Escherichia coli were the most common isolates. Minimal inhibitory concentrations (MIC) measured for half the patients' isolates resulted in 5 regimen changes, including 2 patients with E. cloacae meningitis in whom cephalosporin susceptibility decreased during cephalosporin treatment. Our recommended initial treatment was intravenous ceftriaxone and amikacin, subsequently tailored by susceptibility results; approximately half the patients remained on the antibiotics they started and half were changed to an alternate regimen, most often a carbapenem. Five patients (15%) died, 1 dying after cure of his GNBM. There were no failures in those who received more than 12 d of appropriate treatment: treatment for at least 14 d after the last positive CSF culture guaranteed cure. Initial ceftriaxone and amikacin subsequently changing to susceptibility driven alternatives, often a carbapenem, resulted in cure of 85% of our patients with GNBM.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 20 条
[1]  
[Anonymous], 2000, M7A5 NAT COMM CLIN L, pM7
[2]  
BERK SL, 1980, ANN INTERN MED, V93, P253, DOI 10.7326/0003-4819-93-2-253
[3]  
Brown EM, 2000, BRIT J NEUROSURG, V14, P7
[4]  
CHERUBIN CE, 1989, REV INFECT DIS, V11, P526
[5]   ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].
CHOW, JW ;
FINE, MJ ;
SHLAES, DM ;
QUINN, JP ;
HOOPER, DC ;
JOHNSON, MP ;
RAMPHAL, R ;
WAGENER, MM ;
MIYASHIRO, DK ;
YU, VL .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :585-590
[6]   Characterization of chemical meningitis after neurological surgery [J].
Forgacs, P ;
Geyer, CA ;
Freidberg, SR .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (02) :179-185
[7]   AMIKACIN IN NEWBORN-INFANTS - COMPARATIVE PHARMACOLOGY WITH KANAMYCIN AND CLINICAL EFFICACY IN 45 NEONATES WITH BACTERIAL DISEASES [J].
HOWARD, JB ;
MCCRACKEN, GH ;
TRUJILLO, H ;
MOHS, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (02) :205-210
[8]   POST NEUROSURGERY GRAM-NEGATIVE BACILLARY MENINGITIS [J].
KLASTERSKY, J ;
MOMBELLI, G ;
COPPENS, L ;
DANEAU, D ;
BRIHAYE, J .
JOURNAL OF INFECTION, 1981, 3 :45-51
[9]   GRAM-NEGATIVE BACILLARY MENINGITIS - NEW THERAPY AND CHANGING CONCEPTS [J].
LANDESMAN, SH ;
CHERUBIN, CE ;
CORRADO, ML .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (05) :939-940
[10]   GRAM-NEGATIVE BACILLARY MENINGITIS [J].
LEFROCK, JL ;
SMITH, BR ;
MOLAVI, A .
MEDICAL CLINICS OF NORTH AMERICA, 1985, 69 (02) :243-256